---
figid: PMC9604507__ijms-23-12512-g001
figtitle: Reversible Platelet Integrin AIIbB3 Activation and Thrombus Instability
organisms:
- Homo sapiens
- Mus musculus
- Bos taurus
pmcid: PMC9604507
filename: ijms-23-12512-g001.jpg
figlink: /pmc/articles/PMC9604507/figure/ijms-23-12512-f001/
number: F1
caption: Key signaling pathways in platelets linked to (reversible) integrin activation
  αIIbβ3 and platelet aggregation. For explanations, see text. In short, the IP receptor
  for prostacyclin inhibits platelets via adenylyl cyclase (AC), while gaseous nitric
  oxide inhibits platelets via guanylate cyclase (GC); the formed cAMP and cGMP activate
  protein kinase A (PKA) and protein kinase G (PKG), respectively. As platelet adhesion
  receptors, integrin and GPIb-V-IX interact with fibrinogen, fibrin and von Willebrand
  factor (VWF). The purinoceptors P2Y12 and P2Y1 operate after autocrine release of
  ADP; P2Y12 acts via the G protein Giα, inhibiting AC but stimulating phosphoinositide
  3-kinase (PI3K). On the other hand, P2Y1 signals via Gqα which stimulates phospholipase
  C (PLC), causing Ca2+ release and activation of protein kinase C (PKC). As a strong
  platelet agonist, thrombin also activates Gqα-coupled receptors, namely PAR1 and
  PAR4. The collagen receptor GPVI activates a protein tyrosine kinase pathway involving
  Syk and Btk, leading to downstream activation of PLC and PI3K isoforms, the latter
  stimulating Akt protein kinase. The signaling toward activation of αIIbβ3 furthermore
  involves the small GTPase-regulating proteins CalDAG-GEFI (calcium and diacylglycerol
  regulated guanine nucleotide exchange factor I), Ras3a and Rap1b. The cytoskeleton-linked
  signaling is completed by kindlin and talin isoforms. Black arrows show relative
  strength of pathways to integrin activation; red arrows connected to blue-boxed
  proteins represent inhibitory pathways.
papertitle: Reversible Platelet Integrin αIIbβ3 Activation and Thrombus Instability.
reftext: Jinmi Zou, et al. Int J Mol Sci. 2022 Oct;23(20):12512.
year: '2022'
doi: 10.3390/ijms232012512
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: ADP | collagen | fibrinogen | integrin | platelets | thrombin
automl_pathway: 0.9577817
figid_alias: PMC9604507__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Bos taurus
redirect_from: /figures/PMC9604507__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9604507__ijms-23-12512-g001.html
  '@type': Dataset
  description: Key signaling pathways in platelets linked to (reversible) integrin
    activation αIIbβ3 and platelet aggregation. For explanations, see text. In short,
    the IP receptor for prostacyclin inhibits platelets via adenylyl cyclase (AC),
    while gaseous nitric oxide inhibits platelets via guanylate cyclase (GC); the
    formed cAMP and cGMP activate protein kinase A (PKA) and protein kinase G (PKG),
    respectively. As platelet adhesion receptors, integrin and GPIb-V-IX interact
    with fibrinogen, fibrin and von Willebrand factor (VWF). The purinoceptors P2Y12
    and P2Y1 operate after autocrine release of ADP; P2Y12 acts via the G protein
    Giα, inhibiting AC but stimulating phosphoinositide 3-kinase (PI3K). On the other
    hand, P2Y1 signals via Gqα which stimulates phospholipase C (PLC), causing Ca2+
    release and activation of protein kinase C (PKC). As a strong platelet agonist,
    thrombin also activates Gqα-coupled receptors, namely PAR1 and PAR4. The collagen
    receptor GPVI activates a protein tyrosine kinase pathway involving Syk and Btk,
    leading to downstream activation of PLC and PI3K isoforms, the latter stimulating
    Akt protein kinase. The signaling toward activation of αIIbβ3 furthermore involves
    the small GTPase-regulating proteins CalDAG-GEFI (calcium and diacylglycerol regulated
    guanine nucleotide exchange factor I), Ras3a and Rap1b. The cytoskeleton-linked
    signaling is completed by kindlin and talin isoforms. Black arrows show relative
    strength of pathways to integrin activation; red arrows connected to blue-boxed
    proteins represent inhibitory pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Wdtc1
  - Mdga2
  - P2ry1
  - Vwf
  - Plcb1
  - P2ry12
  - Gnas
  - Gnai2
  - ac
  - Gc
  - Pik3r1
  - Vasp
  - Akt1
  - Rap1b
  - Gp6
  - Rasgrp2
  - Itpr1
  - Syk
  - Btk
  - Prkca
  - Prkcq
  - Napb
  - Vti1b
  - Gosr2
  - Napg
  - Napa
  - F2rl3
  - Met
  - Stk11
  - Pawr
  - Par1
  - Mark2
  - F2r
  - Prkcb
  - WDTC1
  - P2RY1
  - VWF
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - P2RY12
  - GHRH
  - GNAS
  - GNAL
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - PRKG1
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - GC
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - VASP
  - APBB1IP
  - AKT1
  - AKT2
  - AKT3
  - RAP1B
  - MTG1
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - FGA
  - FGB
  - FGG
  - GP6
  - RASGRP1
  - RASGRP2
  - ITPR1
  - ITPR3
  - SYK
  - PLCG1
  - PLCG2
  - BTK
  - ATP2A1
  - ATP2A2
  - ATP2A3
  - PRKCA
  - SNAR-E
  - PAWR
  - F2RL3
  - PWAR4
  - MARK2
  - F2R
  - NR1I2
  - SLC52A2
  - PWAR1
  - PRKCB
  - PRRT2
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - SELE
  - SELL
  - SELP
---
